These novel therapies , Semaglutide , represent a groundbreaking advancement in managing obesity and conceivably other ailments . They all are categorized as GLP-1 hormone stimulators, meaning these substances to replicate the natural GLP-1 hormone , stimulating metabolic secretion and lowering f